New immunotherapy for malignant brain tumors

It is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat advanced cancer. Treatment of brain tumors is particularly challenging because regulatory T-cells accumulate in brain tumors and suppress an immune attack. In several steps using a new strategy and a novel drug, Burkhard Becher's team … Continue reading New immunotherapy for malignant brain tumors